Dec 13, 2022 | Articles

Qinecsa pharmacovigilance consulting guide

Pharmacovigilance consulting is essential throughout the entire lifecycle of both commercial and clinical products. 

At Qinecsa, a company with a strong focus and heritage on pharmacovigilance consulting, with years of successful safety services delivery enhanced by our innovative technologies, we are a proven, trusted partner to the life science industry.

We have successfully helped clients in many areas like people support, process establishment, system selection, and business transformation decisions, leveraging our deep domain expertise in services and technology.

Qinecsa’s suite of pharmacovigilance services includes, and is not limited to:

  • Pharmacovigilance consulting
  • Benefit-risk analysis
  • EEA and local qualified persons for pharmacovigilance (QPPV)
  • Safety Data Exchange Agreement (SDEA)
  • Risk management plans (RMPs) development
  • Pharmacovigilance system master file (PSMF)
  • Auditing services
  • Development of standard operating procedures (SOPs)
  • Post-marketing and clinical trial case processing
  • Validated safety databases
  • Aggregate report writing
  • Literature search
  • Regulatory reporting

Qinecsa supports clients with products authorized or under development in these diverse areas. Our extensive experience and proficiency span various therapeutic areas, including cancer treatments, infectious diseases, oncology, and cardiovascular diseases. 

Qinecsa provides expert consultation on clinical trials and product development. Our medical doctors support trials through serious adverse event (SAE) medical reviews, signaling, and the review of development safety update reports (DSURs).

The expertise of Qinecsa’s pharmacovigilance consulting services is primarily ensured by our industry-renowned experts, alongside our pharmacovigilance technology professionals within our leadership team.

Our team empowers pharmacovigilance strategies, navigating complexities in processes, technology, and vendor optimization. Gain invaluable insights from our experts to elevate your approach and ensure compliance with confidence.

Qinecsa approaches pharmacovigilance consulting as more than just routine. We prioritize offering tailor-made, comprehensive, top-quality, cost-effective, and innovative safety solutions that prioritize the quality of life for patients.

EEA, UK, and local qualified persons for pharmacovigilance (QPPVs) are pivotal in pharmacovigilance consulting. Qinecsa ensures comprehensive training and ongoing updates on key EU PV legislation for its QPPVs. Our robust network of skilled national persons responsible for pharmacovigilance (NPRPs) monitors local regulatory requirements in numerous countries.

EEA, UK, and local QPPVs play a significant role in pharmacovigilance consulting. A QPPV is required for medicinal products marketed within the EEA, overseeing various responsibilities such as establishing and maintaining the marketing authorization holder’s (MAH) PV system, serving as a single point of contact for regulatory authorities, and managing safety concerns. Qinecsa ensures that our QPPVs undergo comprehensive training, share experiences through an internal QPPV forum, and stay updated on crucial EU PV legislation and guidelines changes.

Qinecsa’s pharmacovigilance consulting services extend to audits, inspections, and the preparation of SOPs. The company’s consultants and executives conduct global pharmacovigilance audits and work with client companies to ensure the comprehensive coverage of their pharmacovigilance systems. Creating and reviewing SOPs are ongoing processes tailored to each company and product, ensuring compliance and specificity.

Experienced Project Managers (PMs) at Qinecsa with excellent communication and management skills serve as key contact points for clients, fostering good relationships through regular communication and transparent monthly project status reports.

Empower your pharmacovigilance strategy today by partnering with our experts to ensure optimized, compliant, effective pharmacovigilance solutions that cater to your specific needs while gaining invaluable insights and support. 


Join Qinecsa at DIA Europe 2024

Join Qinecsa at DIA Europe 2024

Qinecsa is excited to be exhibiting for the first time at the DIA Europe regional annual meeting from 12-14 March at the SQUARE Brussels Meeting Centre in Brussels, Belgium. DIA Europe 2024 will focus on sustainability, innovation and collaboration – three key pillars...

Qinecsa company brochure

Qinecsa company brochure

Qinecsa specializes in technology-led, end-to-end pharmacovigilance solutions, built on over 17 years of heritage expertise. As a trusted global partner, we combine best-in-class technology with scientific know-how to connect life science companies with the right...

Reportum pharmacovigilance platform

Reportum pharmacovigilance platform

Reportum is a unified adverse event platform managing both digital and analogue intake from all sources. It offers a digital-first experience for consumers and healthcare professionals, as well as expert pharma users in call centers, PSPs, sales organizations and...